ProQR Therapeutics N.V. Cash Flows From Used In Operating Activities
ProQR Therapeutics N.V. (PRQR) reported Cash Flows From Used In Operating Activities of -EUR 52.79 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-12.
Financial Statements › Cash Flow › Operating Activities
ifrs-full:CashFlowsFromUsedInOperatingActivities · last filed 2026-03-12
- ProQR Therapeutics N.V. cash flows from used in operating activities for the quarter ending 2025-12-31 was -13.36M EUR.
- ProQR Therapeutics N.V. cash flows from used in operating activities for the quarter ending 2025-09-30 was -12.23M EUR.
- ProQR Therapeutics N.V. cash flows from used in operating activities for the quarter ending 2025-06-30 was -11.40M EUR.
- ProQR Therapeutics N.V. cash flows from used in operating activities for the quarter ending 2025-03-31 was -15.80M EUR.
| Period end | Cash Flows From Used In Operating Activities 3 month | Cash Flows From Used In Operating Activities 6 month | Cash Flows From Used In Operating Activities 9 month | Cash Flows From Used In Operating Activities 12 month |
|---|---|---|---|---|
| 2025-12-31 | -13.36M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-03-12 | -25.59M EUR derived: sum of 2 quarters · filed 2026-03-12 | -36.99M EUR derived: sum of 3 quarters · filed 2026-03-12 | -52.79M EUR 20-F · filed 2026-03-12 |
| 2025-09-30 | -12.23M EUR 6-K · filed 2025-11-06 | -23.64M EUR derived: sum of 2 quarters · filed 2025-11-06 | -39.43M EUR 6-K · filed 2025-11-06 | -48.78M EUR derived: sum of 4 quarters · filed 2026-03-12 |
| 2025-06-30 | -11.40M EUR 6-K · filed 2025-08-07 | -27.20M EUR 6-K · filed 2025-08-07 | -36.55M EUR derived: sum of 3 quarters · filed 2026-03-12 | -42.20M EUR derived: sum of 4 quarters · filed 2026-03-12 |
| 2025-03-31 | -15.80M EUR 6-K · filed 2025-05-08 | -25.15M EUR derived: sum of 2 quarters · filed 2026-03-12 | -30.80M EUR derived: sum of 3 quarters · filed 2026-03-12 | -37.06M EUR derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-12-31 | -9.35M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-03-12 | -15.01M EUR derived: sum of 2 quarters · filed 2026-03-12 | -21.26M EUR derived: sum of 3 quarters · filed 2026-03-12 | -36.39M EUR 20-F · filed 2026-03-12 |
| 2024-09-30 | -5.66M EUR 6-K · filed 2025-11-06 | -11.91M EUR derived: sum of 2 quarters · filed 2025-11-06 | -27.05M EUR 6-K · filed 2025-11-06 | -32.37M EUR derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-06-30 | -6.26M EUR 6-K · filed 2025-08-07 | -21.39M EUR 6-K · filed 2025-08-07 | -26.71M EUR derived: sum of 3 quarters · filed 2026-03-12 | -34.22M EUR derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-03-31 | -15.13M EUR 6-K · filed 2025-05-08 | -20.45M EUR derived: sum of 2 quarters · filed 2026-03-12 | -27.96M EUR derived: sum of 3 quarters · filed 2026-03-12 | -38.31M EUR derived: sum of 4 quarters · filed 2026-03-12 |
| 2023-12-31 | -5.32M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-03-12 | -12.83M EUR derived: sum of 2 quarters · filed 2026-03-12 | -23.18M EUR derived: sum of 3 quarters · filed 2026-03-12 | 21.55M EUR 20-F · filed 2026-03-12 |
| 2023-09-30 | -7.51M EUR 6-K · filed 2024-11-07 | -17.86M EUR derived: sum of 2 quarters · filed 2024-11-07 | 26.87M EUR 6-K · filed 2024-11-07 | 9.04M EUR derived: sum of 4 quarters · filed 2025-03-13 |
| 2023-06-30 | -10.35M EUR 6-K · filed 2024-08-08 | 34.38M EUR 6-K · filed 2024-08-08 | 16.55M EUR derived: sum of 3 quarters · filed 2025-03-13 | 1.18M EUR derived: sum of 4 quarters · filed 2025-03-13 |
| 2023-03-31 | 44.73M EUR 6-K · filed 2024-05-09 | 26.89M EUR derived: sum of 2 quarters · filed 2025-03-13 | 11.53M EUR derived: sum of 3 quarters · filed 2025-03-13 | -3.32M EUR derived: sum of 4 quarters · filed 2025-03-13 |
| 2022-12-31 | -17.83M EUR derived: 20-F 12 month − 6-K 9 month · filed 2025-03-13 | -33.20M EUR derived: sum of 2 quarters · filed 2025-03-13 | -48.04M EUR derived: sum of 3 quarters · filed 2025-03-13 | -68.51M EUR 20-F · filed 2025-03-13 |
| 2022-09-30 | -15.36M EUR 6-K · filed 2023-11-07 | -30.21M EUR derived: sum of 2 quarters · filed 2023-11-07 | -50.67M EUR 6-K · filed 2023-11-07 | -46.89M EUR derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | -14.84M EUR 6-K · filed 2023-08-03 | -35.31M EUR 6-K · filed 2023-08-03 | -31.53M EUR derived: sum of 3 quarters · filed 2023-08-03 | -39.58M EUR derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | -20.47M EUR 6-K · filed 2023-05-16 | -16.68M EUR derived: sum of 2 quarters · filed 2023-05-16 | -24.74M EUR derived: sum of 3 quarters · filed 2023-05-16 | -34.72M EUR derived: sum of 4 quarters · filed 2023-05-16 |
| 2021-12-31 | 3.79M EUR 6-K · filed 2022-02-24 | -4.27M EUR derived: sum of 2 quarters · filed 2022-11-09 | -14.25M EUR derived: sum of 3 quarters · filed 2022-11-09 | -26.01M EUR 20-F · filed 2024-03-13 |
| 2021-09-30 | -8.06M EUR 6-K · filed 2022-11-09 | -18.04M EUR derived: sum of 2 quarters · filed 2022-11-09 | -29.80M EUR 6-K · filed 2022-11-09 | -41.55M EUR derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | -9.98M EUR 6-K · filed 2022-08-04 | -21.74M EUR 6-K · filed 2022-08-04 | -33.50M EUR derived: sum of 3 quarters · filed 2022-08-04 | -43.31M EUR derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | -11.76M EUR 6-K · filed 2022-05-05 | -23.52M EUR derived: sum of 2 quarters · filed 2022-05-05 | -33.33M EUR derived: sum of 3 quarters · filed 2022-05-05 | -43.81M EUR derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | -11.76M EUR 6-K · filed 2022-02-24 | -21.57M EUR derived: sum of 2 quarters · filed 2022-02-24 | -32.05M EUR derived: sum of 3 quarters · filed 2022-02-24 | -47.06M EUR 20-F · filed 2023-03-29 |
| 2020-09-30 | -9.81M EUR 6-K · filed 2021-11-04 | -20.30M EUR derived: sum of 2 quarters · filed 2021-11-04 | -35.30M EUR 6-K · filed 2021-11-04 | -47.26M EUR derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | -10.49M EUR 6-K · filed 2021-08-05 | -25.49M EUR 6-K · filed 2021-08-05 | -37.45M EUR derived: sum of 3 quarters · filed 2021-08-05 | -46.22M EUR derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | -15.01M EUR 6-K · filed 2020-05-07 | -26.96M EUR derived: sum of 2 quarters · filed 2021-02-25 | -35.73M EUR derived: sum of 3 quarters · filed 2021-02-25 | -46.61M EUR derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-12-31 | -11.96M EUR 6-K · filed 2021-02-25 | -20.73M EUR derived: sum of 2 quarters · filed 2021-02-25 | -31.61M EUR derived: sum of 3 quarters · filed 2021-02-25 | -43.97M EUR 20-F · filed 2022-04-29 |
| 2019-09-30 | -8.77M EUR 6-K · filed 2020-11-16 | -19.65M EUR derived: sum of 2 quarters · filed 2020-11-16 | -32.01M EUR 6-K · filed 2020-11-16 | -41.12M EUR derived: sum of 4 quarters · filed 2021-03-24 |
| 2019-06-30 | -10.88M EUR 6-K · filed 2020-08-06 | -23.24M EUR 6-K · filed 2020-08-06 | -32.34M EUR derived: sum of 3 quarters · filed 2021-03-24 | -36.60M EUR derived: sum of 4 quarters · filed 2021-03-24 |
| 2019-03-31 | -12.36M EUR 6-K · filed 2020-05-07 | -21.47M EUR derived: sum of 2 quarters · filed 2021-03-24 | -25.72M EUR derived: sum of 3 quarters · filed 2021-03-24 | -31.15M EUR derived: sum of 4 quarters · filed 2021-03-24 |
| 2018-12-31 | -9.10M EUR derived: 20-F 12 month − 6-K 9 month · filed 2021-03-24 | -13.36M EUR derived: sum of 2 quarters · filed 2021-03-24 | -18.78M EUR derived: sum of 3 quarters · filed 2021-03-24 | -28.49M EUR 20-F · filed 2021-03-24 |
| 2018-09-30 | -4.26M EUR 6-K · filed 2019-11-12 | -9.68M EUR derived: sum of 2 quarters · filed 2019-11-12 | -19.39M EUR 6-K · filed 2019-11-12 | |
| 2018-06-30 | -5.42M EUR 6-K · filed 2019-08-07 | -15.13M EUR 6-K · filed 2019-08-07 | ||
| 2017-12-31 | -34.95M EUR 20-F · filed 2020-03-31 | |||
| 2017-06-30 | -9.85M EUR 6-K · filed 2018-08-08 | -18.63M EUR 6-K · filed 2018-08-08 | ||
| 2016-12-31 | -34.22M EUR 20-F · filed 2019-03-28 | |||
| 2015-12-31 | -24.23M EUR 20-F · filed 2018-03-30 |